Jean-Francois Formela net worth and biography

Jean-Francois Formela Biography and Net Worth

Director of ImageneBio

Jean-François Formela is a partner and focuses on novel drug discovery approaches and therapeutics. He joined Atlas Venture in 1993 to build the U.S. life sciences franchise.

He is a director and co-founder of IFM Therapeutics, Intellia Therapeutics (NASDAQ: NTLA), Korro Bio, and Triplet Therapeutics. Jean-François also serves on the boards of Ikena Oncology (NASDAQ: IKNA) and Scorpion Therapeutics.

Some of his prior investments include Arteaus Therapeutics (acquired by Eli Lilly), CoStim Pharmaceuticals (acquired by Novartis), Exelixis (NASDAQ: EXEL) and Translate Bio (NASDAQ: TBIO, acquired by Sanofi).

Jean-François received his M.D. from Paris University School of Medicine and his M.B.A. from Columbia University.

How do I contact Jean-Francois Formela?: The corporate mailing address for Dr. Formela and other ImageneBio executives is 645 SUMMER STREET SUITE 101, BOSTON MA, 02210. ImageneBio can also be reached via phone at 857-273-8343 and via email at [email protected]. Learn More on Jean-Francois Formela's contact information.
Has Jean-Francois Formela been buying or selling shares of ImageneBio?: Jean-Francois Formela has not been actively trading shares of ImageneBio during the last ninety days. Most recently, Jean Francois Formela sold 694 shares of the business's stock in a transaction on Monday, December 13th. The shares were sold at an average price of $175.68, for a transaction totalling $121,921.92. Learn More on Jean-Francois Formela's trading history.
Who are ImageneBio's active insiders?: ImageneBio's insider roster includes Jean-Francois Formela (Director), and Michelle Zhang (Insider). Learn More on ImageneBio's active insiders.
Are insiders buying or selling shares of ImageneBio?: During the last year, ImageneBio insiders bought shares 2 times. They purchased a total of 351,167 shares worth more than $10,499,893.30. The most recent insider tranaction occured on July, 25th when Director David P Bonita bought 83,611 shares worth more than $2,499,968.90. Insiders at ImageneBio own 5.9% of the company. Learn More about insider trades at ImageneBio.
Information on this page was last updated on 7/25/2025.

Jean-Francois Formela Insider Trading History at ImageneBio

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
12/13/2021	Sell	694	$175.68	$121,921.92
12/10/2021	Sell	999	$180.36	$180,179.64
3/30/2021	Buy	10,416	$192.00	$1,999,872.00

Jean-Francois Formela Buying and Selling Activity at ImageneBio

ImageneBio Company Overview

ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. Its lead product includes IMG-007, a non-depleting anti-OX40 mAb that has completed Phase 2a clinical trials for the treatment of atopic dermatitis and alopecia areata. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.

Today's Range

Now: $6.78

$6.59

$7.07

50 Day Range

MA: $7.82

$6.21

$8.79

2 Week Range

Now: $6.78

$6.19

$23.28

Volume

71,806 shs

Average Volume

45,412 shs

Market Capitalization

$75.80 million

P/E Ratio

N/A

Dividend Yield